Optimum duration of dual antiplatelet therapy followed by monotherapy for diabetes after percutaneous coronary intervention with drug-eluting stent implantation: a Bayesian network meta-analysis

Abstract

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited, distributed under the same license, and used for noncommercial purposes only.